Re: Re: Where is the evidence that "HIV" is causally related to KS? 2 September 2004
Previous Rapid Response Next Rapid Response Top
James J Whitehead,
member www.altheal.org
40A Josephine Avenue, London ,SW2 2LA United Kingdom

Send response to journal:
Re: Re: Re: Where is the evidence that "HIV" is causally related to KS?

Dear Nicholas Bennett, Christopher Noble, The Perth group or anybody can anyone please tell me the answers to the following questions in order of importance ( to me and my research) I have searched and searched but cannot yet find the answers to these simple questions would anybody please be so kind as to direct me to published papers that contain the following data. I thank you in advance for your kind assistance.

1. What is the % incidence of Kaposi Sarcoma (not hhv-8 but a kaposi Sarcoma) in Kidney transplant recipients in the Unites States of America. Specificaly kidney transplant recipients not other transplant recipients. ?

2. What is the % incidence of Kaposi Sarcoma (not hhv-8 but Kaposi Sarcoma) In Kidney Transplant recipients in Japan. Specificaly Kidney transplant recipients not other transplant recpients ?

3. What is the % incidence of Kaposi sarcoma (not hhv-8 but Kaposi Sarcoma)In Kidney Transplant recipients in Texas USA. Specificaly Kidney transplant recipients not other transplant recpients ?

4.What is the average % incidence of Kaposi sarcoma (not hhv-8 but Kaposi Sarcoma)In Kidney Transplant recipients in Italy. Specificaly Kidney transplant recipients not other transplant recpients ?

5.What is the average % incidence of Kaposi sarcoma (not hhv-8 but Kaposi Sarcoma)In Kidney Transplant recipients in Spain. Specificaly Kidney transplant recipients not other transplant recpients ?

"Strikingly, KS represents 87.5% of posttransplantation neoplasia in Saudi Arabia (412), and a recent study found KS in 80% of posttransplantation cancers in Turkey (141). In the latter study, KS developed within 1 year in 46% of those cases.

The high frequency of iatrogenic KS in Saudi Arabia reflects the 7% endemic seroprevalence of KSHV in healthy Saudi donors or patients with non-KS malignancies (412).

Interestingly, transplant-associated KS is seen predominantly in kidney allograft recipients and not other solid-organ or bone marrow transplant recipients (230); kidney recipients have a greater than two- fold-higher seroprevalence than those at low risk of KS in France (85)." .(1).

"Although Andreoni et al. found that 21.4% of liver recipients, but only 8.6% of kidney recipients, seroconverted for KSHV, the risk of KS was higher in the kidney transplant recipients." .(1).

The authors of the above state "The high frequency of iatrogenic KS in Saudi Arabia reflects the 7% endemic seroprevalence of KSHV in healthy Saudi donors or patients with non-KS malignancies (412)".(1)

Can anyone else spot why the above statement is clearly very untrue. ?

Best Wishes

Yours Faithfully

James J Whitehead member www.altheal.org

References. (1)MMBR Online

Microbiology and Molecular Biology Reviews, June 2003, p. 175-212, Vol. 67, No. 2 1092-2172/03/$08.00+0 DOI: 10.1128/MMBR.67.2.175-212.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.

http://mmbr.asm.org/cgi/content/full/67/2/175#Iatrogenic%20KS

Iatrogenic KS

Competing interests: Long term Survivor of hiv/oxidative stress/aids Researcher Continuum Magazine,Member of www.altheal.org , clinnical trials volunteer